| Mr Julie H Orozco, OTR/L | |
|
500 W Fort St, Mail Code(117), Boise, ID 83702-4501 | |
| (208) 422-1000 | |
| (208) 422-1241 |
| Full Name | Mr Julie H Orozco |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 500 W Fort St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033216510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT-297 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Julie H Orozco, OTR/L 500 W Fort St, Mail Code(117), Boise, ID 83702-4501 Ph: (208) 422-1000 | Mr Julie H Orozco, OTR/L 500 W Fort St, Mail Code(117), Boise, ID 83702-4501 Ph: (208) 422-1000 |
News Archive
The Fourth U.N. Conference on Least Developed Countries closed in Istanbul on Friday "with a number of recommendations seeking to halve, from 48 to 24, the number of LDCs during the next 10 years," the Guardian's "Global Development" blog reports.
Northstar Healthcare Inc. today announced that it entered into an agreement to acquire certain ownership interests in four physician owned radiation therapy cancer treatment centers from Dr. Chris Phan, a radiation oncologist. Dr. Phan is founder and Chief Executive Officer of Expert Oncology Network Solutions, LLC (EONS). EONS has been instrumental in developing and consulting with cancer centers across Texas.
Encountering bacteria with innocent names such as Pseudomonas aeruginosa and Enterobacteriaceae can lead to hospitalization and - in a worst-case scenario - can also be life-threatening. The bacteria, which cause infections such as pneumonia, frequently develop multi-resistance towards classic antibiotics.
Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.
The addition of the glucagon-like peptide 1 receptor agonist liraglutide improves short-term outcomes and treatment satisfaction in patients who have uncontrolled Type 2 diabetes despite high doses of insulin, shows a randomised trial.
› Verified 4 days ago
Murry Odonnell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-7275 | |
Macaile Hutt, MASTERS IN OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1172 W Franklin Rd, Boise, ID 83709 Phone: 208-375-4200 Fax: 208-375-4201 | |
Eric S Burback, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd Ste 304, Boise, ID 83706 Phone: 208-342-4263 Fax: 208-375-0597 | |
Jennifer K Dennis, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9050 W Overland Rd, Boise, ID 83709 Phone: 208-321-8880 | |
Sarah Ann Oftedal, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5609 S Adonis Pl, Boise, ID 83716 Phone: 208-794-2674 | |
Lisa Hartigan, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 267 E Schmeizer Ln, Boise, ID 83706 Phone: 208-587-0921 |